Trial Profile
Effect of the association between an inhibitor of cholinesterase and the cholinergic precursor choline alfoscerate on cognitive symptoms of Alzheimer's disease associated with vascular damage [Effetto dellassociazione tra un inibitore delle colinesterasi ed il precursore colinergico colina alfoscerato sui sintomi cognitivi e non della malattia di Alzheimer con danno vascolare associato]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2013
Price :
$35
*
At a glance
- Drugs Choline alfoscerate (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms ASCOMALVA
- 26 Aug 2011 New trial record